NCT01910545View on ClinicalTrials.gov

Phase 1 Study of OTS167 in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 23, 2013

Primary Completion Date

April 11, 2016

Study Completion Date

May 4, 2016

Conditions
Solid TumorsMetastatic Tumors
Interventions
DRUG

OTS167IV

Trial Locations (1)

60637

University of Chicago, Chicago

Sponsors
All Listed Sponsors
lead

OncoTherapy Science, Inc.

INDUSTRY

NCT01910545 - Phase 1 Study of OTS167 in Patients With Solid Tumors | Biotech Hunter | Biotech Hunter